LAB
Standard BioTools, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.62
+0.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.96x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.44x
- Price / sales
- 2.88x
- Price / cash flow
- -3.78x
Enterprise value
- Enterprise value
- -$191.1M
- EV / sales
- -2.26x
- EV / EBITDA
- 2.34x
- EV / EBIT
- 2.50x
- Market cap
- $243.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026